Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.4% |
| 2 | Technology | 18.51% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Financials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Imunon
IMNN
$6.68M
| $90K | ﹤0.01% |
4,103
+92
| +2% | +$2.58K |
|
3627
Lipocine
LPCN
$17.9M
| $90K | ﹤0.01% |
11,729
+6,964
| +146% | +$77.8K |
|
3628
Moleculin Biotech
MBRX
$2.76M
| $90K | ﹤0.01% |
225
-10
| -4% | -$5.79K |
|
|
SGRP
3629
DELISTED
SPAR Group
SGRP
| $90K | ﹤0.01% |
62,000
-23,100
| -27% | -$29.8K |
|
|
QXO
3630
QXO Inc
QXO
$16.5B
| $90K | ﹤0.01% |
3,991
+316
| +9% | +$7.74K |
|
|
NIXX
3631
Nixxy Inc
NIXX
$15.3M
| $90K | ﹤0.01% |
4,913
-1,300
| -21% | -$25.7K |
|
|
SUNW
3632
DELISTED
Sunworks, Inc.
SUNW
| $90K | ﹤0.01% |
32,228
-722,172
| -96% | -$2.03M |
|
3633
Eledon Pharmaceuticals
ELDN
$266M
| $88K | ﹤0.01% |
31,873
-300
| -0.9% | -$955 |
|
3634
Rush Street Interactive
RSI
$2.67B
| $88K | ﹤0.01% |
23,800
+13,200
| +125% | +$69.8K |
|
|
AUMN
3635
DELISTED
Golden Minerals Company
AUMN
| $88K | ﹤0.01% |
13,672
+4,524
| +49% | +$33.1K |
|
|
RIBT
3636
DELISTED
RiceBran Technologies
RIBT
| $88K | ﹤0.01% |
48,968
-3,838
| -7% | -$11.1K |
|
3637
Arbutus Biopharma
ABUS
$913M
| $87K | ﹤0.01% |
+45,660
| New | +$107K |
|
3638
Vista Gold
VGZ
$290M
| $87K | ﹤0.01% |
165,541
-71,538
| -30% | -$42K |
|
3639
Perspective Therapeutics
CATX
$335M
| $86K | ﹤0.01% |
37,213
-496
| -1% | -$1.7K |
|
3640
ENDRA Life Sciences
NDRA
$5.77M
| $86K | ﹤0.01% |
8
-8
| -50% | -$82.6K |
|
|
AGPU
3641
Axe Compute Inc
AGPU
$105M
| $86K | ﹤0.01% |
795
-555
| -41% | -$68.6K |
|
3642
Recon Technology
RCON
$5.76M
| $86K | ﹤0.01% |
8,417
-227
| -3% | -$2.73K |
|
3643
Paranovus Entertainment Technology
PAVS
$4.24M
| – | – |
0
| – | – |
|
|
BFI
3644
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| $85K | ﹤0.01% |
32,720
-89,180
| -73% | -$274K |
|
|
IMPL
3645
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $85K | ﹤0.01% |
17,400
+200
| +1% | +$1.53K |
|
3646
Farmmi Inc
FAMI
$5.99M
| $84K | ﹤0.01% |
1,570
-2,606
| -62% | -$240K |
|
3647
Solana Company
HSDT
$100M
| $84K | ﹤0.01% |
8
+7
| +700% | +$193K |
|
|
FRMM
3648
Forum Markets
FRMM
$82.3M
| $83K | ﹤0.01% |
33
+3
| +10% | +$10.9K |
|
3649
Creative Realities
CREX
$39.9M
| $83K | ﹤0.01% |
46,333
+1,833
| +4% | +$3.53K |
|
3650
Werewolf Therapeutics
HOWL
$19.5M
| $83K | ﹤0.01% |
18,300
+1,500
| +9% | +$8.14K |
|
Similar funds
Renaissance Technologies's Q3 2022 Portfolio in Review
As of Q3 2022, Renaissance Technologies held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class A worth $498M.
- Renaissance Technologies's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Renaissance Technologies added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Renaissance Technologies's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Renaissance Technologies fully exited Shopify in Q3 2022, selling an estimated $439M.
- Renaissance Technologies's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Renaissance Technologies opened 440 new positions and closed 637 in Q3 2022.
- Renaissance Technologies's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.